CbdMD Capital Expenditures from 2010 to 2025

YCBD Stock  USD 0.26  0.01  3.70%   
CbdMD's Capital Expenditures is increasing over the years with stable fluctuation. Capital Expenditures is expected to dwindle to about 316.8 K. During the period from 2010 to 2025 CbdMD Capital Expenditures annual values regression line had geometric mean of  316,644 and mean square error of 366.7 B. View All Fundamentals
 
Capital Expenditures  
First Reported
2016-09-30
Previous Quarter
110 K
Current Value
164.4 K
Quarterly Volatility
409.1 K
 
Covid
Check CbdMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CbdMD's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 98.9 K or Interest Expense of 17.7 K, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 1.66 or PTB Ratio of 1.13. CbdMD financial statements analysis is a perfect complement when working with CbdMD Valuation or Volatility modules.
  
Check out the analysis of CbdMD Correlation against competitors.

Latest CbdMD's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of cbdMD Inc over the last few years. Capital Expenditures are funds used by cbdMD Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of CbdMD operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is CbdMD's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CbdMD's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Pretty Stable
   Capital Expenditures   
       Timeline  

CbdMD Capital Expenditures Regression Statistics

Arithmetic Mean539,520
Geometric Mean316,644
Coefficient Of Variation112.00
Mean Deviation430,166
Median297,549
Standard Deviation604,267
Sample Variance365.1B
Range2.3M
R-Value0.25
Mean Square Error366.7B
R-Squared0.06
Significance0.35
Slope31,786
Total Sum of Squares5.5T

CbdMD Capital Expenditures History

2025316.8 K
2024333.5 K
2023290 K
2022297.5 K
2021688.7 K
20202.3 M
20191.3 M

About CbdMD Financial Statements

CbdMD stakeholders use historical fundamental indicators, such as CbdMD's Capital Expenditures, to determine how well the company is positioned to perform in the future. Although CbdMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in CbdMD's assets and liabilities are reflected in the revenues and expenses on CbdMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in cbdMD Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Expenditures333.5 K316.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
Check out the analysis of CbdMD Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.90)
Revenue Per Share
7.06
Quarterly Revenue Growth
(0.15)
Return On Assets
(0.16)
Return On Equity
(1.35)
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.